COMPASS INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Long-term Stockholders of Compass Diversified to Inquire About Their Rights

(NYSE:CODI), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Compass (CODI) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Compass between May 1, 2024, to May 7, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire […]

A&K Robotics Partners with Aena to Redefine Passenger Experience at Adolfo Suarez Madrid-Barajas Airport

A&K Robotics Partners with Aena to Redefine Passenger Experience at Adolfo Suarez Madrid-Barajas Airport GlobeNewswire October 29, 2025 MADRID, Oct. 29, 2025 (GLOBE NEWSWIRE) — A&K Robotics, the autonomous micromobility company, and Aena, the world's largest airport operator by passenger numbers, announce that they have entered a collaboration agreement to pilot Cruz mobility pods at

COMPASS INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Long-term Stockholders of Compass Diversified to Inquire About Their Rights

COMPASS INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Long-term Stockholders of Compass Diversified to Inquire About Their Rights GlobeNewswire October 29, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Compass (CODI) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in

Canadian Investment Regulatory Organization Trading Halt – CCE

The following issues have been halted by CIRO Company: Commerce Resources Corp. TSX-Venture Symbol: CCE All Issues: Yes Reason: At the request of the Listing Exchange Halt Time (ET): 7:55 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented

15th Annual Maple Leaf Foods’ Food Safety Symposium Calls for Renewed Vigilance to Reduce Foodborne Illness from Listeria

Maple Leaf Foods Inc.(TSX: MFI) hosted the 15th annual Food Safety Symposium in Mississauga Ontario on October 21, 2025. The event, titled “How many more wake up calls? Confronting the Listeria threat – reclaiming control before the next crisis,” brought together hundreds of food safety professionals to discuss and engage on the alignment and intersection

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Rigel Pharmaceuticals,Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2025 financial results after market close on Tuesday, November 4, 2025.Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update

FLEX REPORTS SECOND QUARTER FISCAL 2026 RESULTS

— Reported net sales up 4%, at the top end of our guidance. — Raising full-year net sales, adjusted operating margin and adjusted EPS guidance due to strong data center demand in our Power and Cloud businesses and continued disciplined execution. — Delivered GAAP operating margin of 4.4%, and adjusted operating margin of 6.0% marking

Genpact Recognized by Forbes as One of the World’s Best Employers 2025

Recognition for the fifth consecutive year reaffirms Genpact's ongoing commitment to fostering a culture of continuous learning, innovation, and career growth Genpact (NYSE: G), an agentic and advanced technology solutions company recognized for its deep industry knowledge, process intelligence, and last-mile expertise, today announced its inclusion on the annual Forbes list of “World's Best Employers

Johnson & Johnson announces first head-to-head study comparing IMAAVY™ with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting

The EPIC study will evaluate treatment with IMAAVY™ versus efgartigimod in adults with gMG and will include a treatment-switch arm The Company also announced new data from the pivotal Vibrance-MG study in which pediatric patients receiving treatment with IMAAVY™ demonstrated 72 weeks of sustained reduction in immunoglobulin G (IgG), sustained disease control and no new

Fresche Solutions Launches Db2 Web Query Alternative, Bridging IBM i Data with Modern Microsoft BI and AI

MONTREAL, Oct. 29, 2025 (GLOBE NEWSWIRE) — Fresche Solutions today announced the launch of the Fresche Db2 Analytics Accelerator, an innovative solution designed to help IBM i organizations modernize their business intelligence capabilities. The new accelerator provides a secure, high-performance bridge between mission-critical IBM i Db2 data and the advanced analytics capabilities of Microsoft Fabric

Scroll to Top